These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 32767959)
1. Docking Studies and Antiproliferative Activities of 6-(3-aryl-2-propenoyl)-2(3H)- benzoxazolone Derivatives as Novel Inhibitors of Phosphatidylinositol 3-Kinase (PI3Kα). Bilginer S; Bardaweel SK; Sabbah DA; Gul HI Anticancer Agents Med Chem; 2021; 21(6):716-724. PubMed ID: 32767959 [TBL] [Abstract][Full Text] [Related]
2. Benzoin Schiff Bases: Design, Synthesis, and Biological Evaluation as Potential Antitumor Agents. Sabbah DA; Al-Tarawneh F; Talib WH; Sweidan K; Bardaweel SK; Al-Shalabi E; Zhong HA; Abu Sheikha G; Abu Khalaf R; Mubarak MS Med Chem; 2018; 14(7):695-708. PubMed ID: 29651943 [TBL] [Abstract][Full Text] [Related]
3. Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents. Sabbah DA; Hishmah B; Sweidan K; Bardaweel S; AlDamen M; Zhong HA; Abu Khalaf R; Hasan Ibrahim A; Al-Qirim T; Abu Sheikha G; Mubarak MS Anticancer Agents Med Chem; 2018; 18(2):263-276. PubMed ID: 28901259 [TBL] [Abstract][Full Text] [Related]
4. Ligand-Based Drug Design: Synthesis and Biological Evaluation of Substituted Benzoin Derivatives as Potential Antitumor Agents. Sabbah DA; Ibrahim AH; Talib WH; Alqaisi KM; Sweidan K; Bardaweel SK; Sheikha GA; Zhong HA; Al-Shalabi E; Khalaf RA; Mubarak MS Med Chem; 2019; 15(4):417-429. PubMed ID: 30207238 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing sulfonamido as potential PI3Kα inhibitors. Yin Y; Hu JQ; Wu X; Sha S; Wang SF; Qiao F; Song ZC; Zhu HL Bioorg Med Chem; 2019 Jun; 27(11):2261-2267. PubMed ID: 31029551 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological activity of novel 2,3,4,5-tetra-substituted thiophene derivatives as PI3Kα inhibitors with potent antitumor activity. Liao W; Wang Z; Han Y; Qi Y; Liu J; Xie J; Tian Y; Lei Q; Chen R; Sun M; Tang L; Gong G; Zhao Y Eur J Med Chem; 2020 Jul; 197():112309. PubMed ID: 32375077 [TBL] [Abstract][Full Text] [Related]
7. Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing piperazine as inhibitors of PI3Kα. Yin Y; Zhou Y; Sha S; Wu X; Wang SF; Qiao F; Song ZC; Zhu HL Bioorg Chem; 2019 Nov; 92():103238. PubMed ID: 31499259 [TBL] [Abstract][Full Text] [Related]
8. Molecular modeling based approach, synthesis, and cytotoxic activity of novel benzoin derivatives targeting phosphoinostide 3-kinase (PI3Kα). Sabbah DA; Saada M; Khalaf RA; Bardaweel S; Sweidan K; Al-Qirim T; Al-Zughier A; Halim HA; Sheikha GA Bioorg Med Chem Lett; 2015 Aug; 25(16):3120-4. PubMed ID: 26099539 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer evaluation of novel 1H-benzo[d]imidazole derivatives of dehydroabietic acid as PI3Kα inhibitors. Yang YQ; Chen H; Liu QS; Sun Y; Gu W Bioorg Chem; 2020 Jul; 100():103845. PubMed ID: 32344183 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Apoptotic Activities of New 2(3H)-benzoxazolone Derivatives in Breast Cancer Cells. Erdag E; Becer E; Mulazim Y; Vatansever HS; Kabadayı H; Kesanli B Anticancer Agents Med Chem; 2021; 21(1):84-90. PubMed ID: 32698749 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of novel 6-(pyridin-3-yl) quinazolin-4(3H)-one derivatives as potential anticancer agents via PI3K inhibition. Yang H; Li Q; Su M; Luo F; Liu Y; Wang D; Fan Y Bioorg Med Chem; 2021 Sep; 46():116346. PubMed ID: 34403956 [TBL] [Abstract][Full Text] [Related]
12. Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases. Sabbah DA; Simms NA; Brattain MG; Vennerstrom JL; Zhong H Bioorg Med Chem Lett; 2012 Jan; 22(2):876-80. PubMed ID: 22212721 [TBL] [Abstract][Full Text] [Related]
13. Novel 4-aminoquinazoline derivatives induce growth inhibition, cell cycle arrest and apoptosis via PI3Kα inhibition. Fan YH; Ding HW; Liu DD; Song HR; Xu YN; Wang J Bioorg Med Chem; 2018 May; 26(8):1675-1685. PubMed ID: 29475582 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors. Fan YH; Li W; Liu DD; Bai MX; Song HR; Xu YN; Lee S; Zhou ZP; Wang J; Ding HW Eur J Med Chem; 2017 Oct; 139():95-106. PubMed ID: 28800461 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of 2, 6, 8-substituted Imidazopyridine derivatives as potent PI3K Chen R; Wang Z; Sima L; Cheng H; Luo B; Wang J; Guo B; Mao S; Zhou Z; Peng J; Tang L; Liu X; Liao W J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2155638. PubMed ID: 36650905 [TBL] [Abstract][Full Text] [Related]
16. Difuran-substituted quinoxalines as a novel class of PI3Kα H1047R mutant inhibitors: Synthesis, biological evaluation and structure-activity relationship. Zhang N; Yu Z; Yang X; Zhou Y; Tang Q; Hu P; Wang J; Zhang SL; Wang MW; He Y Eur J Med Chem; 2018 Sep; 157():37-49. PubMed ID: 30071408 [TBL] [Abstract][Full Text] [Related]
17. Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates bearing sulfonylpiperazine as antitumor inhibitors targeting PI3Kα. Yin Y; Sha S; Wu X; Wang SF; Qiao F; Song ZC; Zhu HL Eur J Med Chem; 2019 Nov; 182():111630. PubMed ID: 31446244 [TBL] [Abstract][Full Text] [Related]
18. Computer-aided design, synthesis, and biological evaluation of new indole-2-carboxamide derivatives as PI3Kα/EGFR inhibitors. Sweidan K; Sabbah DA; Bardaweel S; Dush KA; Sheikha GA; Mubarak MS Bioorg Med Chem Lett; 2016 Jun; 26(11):2685-90. PubMed ID: 27084677 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of some 1,6-disubstituted-1H-benzo[d]imidazoles derivatives targeted PI3K as anticancer agents. Ding HW; Yu L; Bai MX; Qin XC; Song MT; Zhao QC Bioorg Chem; 2019 Dec; 93():103283. PubMed ID: 31585260 [TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, Biological Evaluation, and Molecular Modeling of 2-Difluoromethylbenzimidazole Derivatives as Potential PI3Kα Inhibitors. Wang X; Zhang M; Zhu R; Wu Z; Wu F; Wang Z; Yu Y Molecules; 2022 Jan; 27(2):. PubMed ID: 35056702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]